http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3913310-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C401-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00
filingDate 1989-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bef194b1b97ea6a779a046906491bed5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0013552a1230a8354222007a67a7f65a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75e7996c63226489d88e23b9ce896049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84bbc71d8fbe6ed18b06fe65fde4021c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7d31296d4ab95cff2c5c2062e030baf
publicationDate 1990-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-3913310-A1
titleOfInvention SPIROCYCLOPROPANE IN THE VITAMIN D SERIES
abstract 9,10-Secopregnane derivs. of formula (I) are new. In (I), R1 is 1-10C alkyl or 2-10C alkenyl, opt. contg. 1-3 additional functional gps. R2 and R3 are H, 1-6C alkanoyl, or 3-6C alkenoyl. Specific (I) are alpha-hydroxy-10,19 methylene-ergocalciferol alpha-hydroxy-10,19- methylene-cholecalciferol, alpha,25-dihydroxy-10,19 methylene-chlorocalciferol. USE/ADVANTAGE - (I) are vitamin D analogues with approx. the same activity as known vitamin D cpds. (contg. a 10,19 double bond) w.r.t. proliferation inhibiton and cell differentiation, but with reduced activity w.r.t. Ca and phosphate metabolisation and with better chemical stability. They may be used in the treatment of tumours, psoriasis, etc.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0972762-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6017907-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9501960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0972762-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-699200-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1103755-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8193249-B2
priorityDate 1989-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12303103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451547506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426586890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061

Total number of triples: 39.